USE OF PROTEIN KINASE C DELTA (PKCD) INHIBITORS TO TREAT DIABETES, OBESITY, AND HEPATIC STEATOSIS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120208750A1
SERIAL NO

13497172

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described are methods of improving insulin sensitivity, and treating fatty liver disease (including non-alcoholic steatohepatitis (NASH)), by administering specific inhibitors of PKC delta.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JOSLIN DIABETES CENTER INCONE JOSLIN PLACE BOSTON MA 02215

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bezy, Olivier Milton, US 1 8
Kahn, C Ronald West Newton, US 30 199

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation